Clinical trials
Not yet recruiting Endometrial Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
94 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 11 |
| 2025 | 22 |
| 2026 | 49 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Not yet recruiting | 94 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 5 |
| Peking University People's Hospital | 4 |
| European Institute of Oncology | 3 |
| GlaxoSmithKline | 3 |
| Peking Union Medical College Hospital | 3 |
| Advenchen Pharmaceuticals, LLC. | 2 |
| Convalife (Shanghai) Co., Ltd. | 2 |
| Fudan University | 2 |
| Fujian Cancer Hospital | 2 |
| Haihua Yuan | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Endometrial Neoplasms | 94 |
| Ovarian Neoplasms | 22 |
| Uterine Cervical Neoplasms | 15 |
| Breast Neoplasms | 10 |
| Colorectal Neoplasms | 9 |
| Endometrial Hyperplasia | 9 |
| Stomach Neoplasms | 9 |
| Carcinoma, Non-Small-Cell Lung | 6 |
| Neoplasms | 6 |
| Pancreatic Neoplasms | 6 |
Trials
Showing 51 to 75 of 94. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.